Difamilast for the treatment of atopic dermatitis.

J Int Med Res · 2023 · PMC10328024 · PMID 37389929

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Patients in both drug-treated groups also had highly significant IGA score success rates compared with the vehicle group at weeks 1 and 2. 23 During the study, TEAEs were observed in 33.0% of patients on 0.3% difamilast, 34.0% of patients on 1% difamilast and 34.0% on the vehicle.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.